CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 40 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $11,000 | +450.0% | 605 | +476.2% | 0.00% | – |
| Q3 2020 | $2,000 | – | 105 | +425.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 20 | -70.6% | 0.00% | – |
| Q1 2020 | $1,000 | -92.9% | 68 | -92.2% | 0.00% | – |
| Q4 2019 | $14,000 | +180.0% | 877 | +252.2% | 0.00% | – |
| Q3 2018 | $5,000 | – | 249 | +8200.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 3 | -99.5% | 0.00% | – |
| Q1 2017 | $6,000 | -40.0% | 550 | -26.2% | 0.00% | – |
| Q4 2016 | $10,000 | – | 745 | +9212.5% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 8 | -98.4% | 0.00% | – |
| Q3 2015 | $8,000 | -61.9% | 496 | -11.0% | 0.00% | – |
| Q2 2015 | $21,000 | – | 557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PLATINUM INVESTMENT MANAGEMENT LTD | 672,885 | $11,123,000 | 0.26% |
| AWM Investment Company, Inc. | 80,165 | $1,325,000 | 0.25% |
| Nikko Asset Management Americas, Inc. | 532,318 | $8,799,000 | 0.17% |
| ARK Investment Management | 314,378 | $5,197,000 | 0.13% |
| Sumitomo Mitsui Trust Holdings, Inc. | 528,418 | $8,735,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 32,100 | $531,000 | 0.01% |
| Mizuho Securities Co. Ltd. | 300 | $5,000 | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 148,815 | $2,459,000 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 18,629 | $308,000 | 0.00% |
| STATE OF WISCONSIN INVESTMENT BOARD | 16,100 | $237,000 | 0.00% |